Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Jessica Altman

Leukemia · Northwestern Medicine

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    GMDr. Gerald Marti

    Dr. Gerald Marti

    Hematology & Oncology · Leukemia
    National Institutes of Health (NIH)
    geraldm

    Research

    International Clinical Cytometry Society 2023 workload survey of clinical flow cytometry laboratories

    2025

    Via Cytometry. Part B, Clinical Cytometry

    Research

    EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

    2024

    Via Blood

    Research

    Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia

    2023

    Via Frontiers in Genetics

    Research

    Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

    2021

    Via Blood

    Research

    Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

    2021

    Via Blood

    Research

    Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

    2021

    Via Leukemia & Lymphoma

    Research

    Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma

    2021

    Via Leukemia & Lymphoma

    Research

    Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance

    2020

    Via Journal of Toxicology and Environmental Health, Part A

    Research

    Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

    2018

    Via Blood

    Research

    Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood

    2017

    Via Leukemia

    Research

    Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease

    2016

    Via Cytometry. Part B, Clinical Cytometry

    Research

    Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)

    2016

    Via PLoS One

    Research

    Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia

    2016

    Via JAMA Dermatology

    Research

    Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia

    2016

    Via Oncotarget

    Research

    Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility

    2016

    Via Blood